Top Tweets for #psychedelicScience

4 months ago

PharmAla licenses its next-gen MDMA drug candidate ALA-002 to Jupiter Neurosciences in a $100M+ U.S. deal. $mdma #psychedelics #psychedelicscience

2

13

5

2

2K

Psychedelic Magazine @PsychedelicMgzn

4 months ago

PharmAla is pleased to announce that it has executed a definitive SPV Formation called Restora Neurosciences to lead the clinical and regulatory development of APA-01. $mdma #psychedelic #psychedelicscience

1

15

4

1

1K

4 months ago

🚬🍄 Can psilocybin actually help people quit smoking? New clinical research suggests the answer might be yes. Full story: https://t.co/lE6n8JjBZ1 #Psilocybin #MagicMushrooms #SmokingCessation #Psychedelics #MentalHealth #Neuroscience #AddictionRecovery #PsychedelicScience

PsychedelicMgzn's tweet photo. 🚬🍄 Can psilocybin actually help people quit smoking?

New clinical research suggests the answer might be yes.

Full story: https://t.co/lE6n8JjBZ1

#Psilocybin #MagicMushrooms #SmokingCessation #Psychedelics #MentalHealth #Neuroscience #AddictionRecovery #PsychedelicScience https://t.co/xR789vTEez

0

3

0

48

Clearmind Medicine

@ClearmindCMND

5 months ago

Learn more about Clearmind Medicine: https://t.co/8lEiW9xZCP #MEAI #FDA #CMND #AUD #CMND100 #VA #alcoholusedisorder #biotechnology #psychedelicscience #neuroplastogen #treatment #mentalhealth #innovation #executiveorder #yale #johnshopkins $CMND

ClearmindCMND's tweet photo. Learn more about Clearmind Medicine: https://t.co/8lEiW9xZCP

#MEAI #FDA #CMND #AUD #CMND100 #VA #alcoholusedisorder #biotechnology #psychedelicscience #neuroplastogen #treatment #mentalhealth #innovation #executiveorder #yale #johnshopkins $CMND https://t.co/pqAGAXPmN1

0

3

1

0

143

5 months ago

PharmAla & Aluvaris have executed a binding LOI to form an SPV for the clinical & regulatory development of APA-01 (P-1), our patented novel MDXX molecule. $mdma #psychedeleics #psychedelicscience

1

12

5

0

537

5 months ago

PharmAla CEO, Nick Kadysh, speaks on the recent Executive Order to ease psychedelic drug restrictions and accelerate research on psychedelic therapies. $mdma #psychedelic #psychedelicscience

1

9

3

1

586

Edward Shalts, MD, ABPN

@dr_shalts

5 months ago

Ibogaine — the powerful root from Central Africa showing remarkable potential for resetting addiction and trauma pathways. Ancient wisdom meets emerging science. What are your thoughts on plant-based healing? #Ibogaine #PsychedelicScience #AddictionRecovery

dr_shalts's tweet photo. Ibogaine — the powerful root from Central Africa showing remarkable potential for resetting addiction and trauma pathways. Ancient wisdom meets emerging science. What are your thoughts on plant-based healing? #Ibogaine #PsychedelicScience #AddictionRecovery https://t.co/6QkmHYGMJ1

1

2

1

87

5 months ago

PharmAla is pleased to have publicly filed its financial and operational results for the period ended February 28, 2026. $mdma #psychedelics #psychedelicscience

1

11

2

1

422

5 months ago

PharmAla responds to the Executive Order signed by the President of the United States to establish a pathway for eligible patients to access investigational psychedelic drugs. $mdma #psychedelic #psychedelicscience

1

13

7

2

893

7 months ago

Psychedelic clinical trials measure important outcomes. But the people who go through these experiences often see dimensions of healing & challenge that standard frameworks miss. #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience

psych_lived_exp's tweet photo. Psychedelic clinical trials measure important outcomes.

But the people who go through these experiences often see dimensions of healing & challenge that standard frameworks miss.

#PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience https://t.co/xUgpHGCeSE

2

0

27

7 months ago

Destigmatization, Legalization, and Why Clear Rules Protect Patients Meet Janina Kowalski, MD, a psychiatrist who underwent ketamine, MDMA, LSD, and psilocybin in experiential therapist training. #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #PsychedelicScience

2

4

0

233

7 months ago

Beyond Lip Service: Meaningful Inclusion of Lived Experience Meet Simon Amar, MD, a psychiatrist and investigator for MDMA for PTSD and psilocybin for anxiety clinical trials #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience

3

1

0

106

7 months ago

MDMA-Assisted Therapy Trial: Safety, Trust, and Returning to Work Meet Sehrish Sayani, who participated in a Phase 3 MDMA-assisted therapy clinical trial for PTSD. #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience #Psychedelics

2

3

2

0

95